Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Adjuvant chemoradiotherapy plus pembrolizumab for locally advanced esophageal squamous cell carcinoma with high risk of recurrence following neoadjuvant chemoradiotherapy: a single-arm phase II study ; volume:73 ; number:11 ; day:9 ; month:9 ; year:2024 ; pages:1-11 ; date:11.2024
Cancer immunology immunotherapy ; 73, Heft 11 (9.9.2024), 1-11, 11.2024
- Urheber
-
Guo, Jhe-Cyuan
Huang, Ta-Chen
Kuo, Hung-Yang
Lin, Chia-Chi
Hsu, Feng-Ming
Cheng, Jason Chia-Hsien
Huang, Yen-Lin
Hsieh, Min-Shu
Huang, Pei-Ming
Lee, Jang-Ming
Wu, Shu-Ling
Hsu, Chih-Hung
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-024-03826-y
- URN
-
urn:nbn:de:101:1-2501142100184.232058786129
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Guo, Jhe-Cyuan
- Huang, Ta-Chen
- Kuo, Hung-Yang
- Lin, Chia-Chi
- Hsu, Feng-Ming
- Cheng, Jason Chia-Hsien
- Huang, Yen-Lin
- Hsieh, Min-Shu
- Huang, Pei-Ming
- Lee, Jang-Ming
- Wu, Shu-Ling
- Hsu, Chih-Hung
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Prediction of pathological response to neo‐adjuvant chemoradiotherapy for oesophageal cancer using vibrational spectroscopy
Concurrent chemoradiotherapy in adjuvant treatment of breast cancer
Adjuvant Therapy for Patients with a Tumor-Positive Resection Margin After Neoadjuvant Chemoradiotherapy and Esophagectomy
Analysis of early postoperative complications in patients with resectable rectal cancer after neo-adjuvant chemo-radiotherapy
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Can neoadjuvant chemoradiotherapy affect exfoliated cancer cells in colorectal cancer?
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : 2. Addendum zum Projekt A24-46
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : Addendum zum Projekt A24-46 (Dossierbewertung)
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Prediction of pathological response to neo‐adjuvant chemoradiotherapy for oesophageal cancer using vibrational spectroscopy
Concurrent chemoradiotherapy in adjuvant treatment of breast cancer
Adjuvant Therapy for Patients with a Tumor-Positive Resection Margin After Neoadjuvant Chemoradiotherapy and Esophagectomy
Analysis of early postoperative complications in patients with resectable rectal cancer after neo-adjuvant chemo-radiotherapy
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Can neoadjuvant chemoradiotherapy affect exfoliated cancer cells in colorectal cancer?
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : 2. Addendum zum Projekt A24-46
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : Addendum zum Projekt A24-46 (Dossierbewertung)
Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies
Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancer
Prediction of pathological response to neo‐adjuvant chemoradiotherapy for oesophageal cancer using vibrational spectroscopy
Concurrent chemoradiotherapy in adjuvant treatment of breast cancer
Adjuvant Therapy for Patients with a Tumor-Positive Resection Margin After Neoadjuvant Chemoradiotherapy and Esophagectomy
Analysis of early postoperative complications in patients with resectable rectal cancer after neo-adjuvant chemo-radiotherapy
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Can neoadjuvant chemoradiotherapy affect exfoliated cancer cells in colorectal cancer?
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : Nutzenbewertung gemäß § 35a SGB V; Dossierbewertung
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : 2. Addendum zum Projekt A24-46
Pembrolizumab (NSCLC, neoadjuvant + adjuvant) : Addendum zum Projekt A24-46 (Dossierbewertung)